Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VcanBio Cell & Gene Engineering Corp., Ltd. is a leading Chinese biotechnology company specializing in the integration of cell therapy, genetic testing, and precision medicine. The company operates an extensive network of stem cell banks across China, providing comprehensive storage services for cord blood, umbilical cord, and adipose-derived stem cells. Through its Center for Translational Biotechnology, VcanBio advances a diverse pipeline of regenerative medicine and oncology treatments, including mesenchymal stem cell therapies and CAR-T cell products. Publicly traded on the Shanghai Stock Exchange, the company maintains robust infrastructure for GMP-compliant cell manufacturing and clinical diagnostics to support its "cell storage, gene testing, and precision medicine" business model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VcanBio Center for Translational Biotechnology.